Two pharmacy specialists discuss real-world data and clinical trial findings on the use of CAR T-cell therapy for pediatric patients with hematologic cancers.
Terri Lynn Shigle, PharmD
Advertisement
Articles by Terri Lynn Shigle, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Withdrawal Planned for Second-Line Lurbinectedin in SCLC Indication
2
Does Patient Selection Inflate CAR T Outcomes in Multiple Myeloma?
3
Changing Chemotherapy Delivery in BCG-Unresponsive Bladder Cancer
4
Why CAR T-Cell Therapy Should Precede Bispecifics in Multiple Myeloma
5